List of Tables
Table 1. Global AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Software
Table 3. Key Players of Services
Table 4. Key Players of Hardware
Table 5. Global AI for Clinical and Molecular Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 8. Global AI for Clinical and Molecular Diagnostics Market Share by Region (2021–2026)
Table 9. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global AI for Clinical and Molecular Diagnostics Market Share by Region (2027–2032)
Table 11. AI for Clinical and Molecular Diagnostics Market Trends
Table 12. AI for Clinical and Molecular Diagnostics Market Drivers
Table 13. AI for Clinical and Molecular Diagnostics Market Challenges
Table 14. AI for Clinical and Molecular Diagnostics Market Restraints
Table 15. Global AI for Clinical and Molecular Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 16. Global AI for Clinical and Molecular Diagnostics Market Share by Players (2021–2026)
Table 17. Global Top AI for Clinical and Molecular Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI for Clinical and Molecular Diagnostics Revenue, 2025
Table 18. Ranking of Global Top AI for Clinical and Molecular Diagnostics Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by AI for Clinical and Molecular Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of AI for Clinical and Molecular Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of AI for Clinical and Molecular Diagnostics, Products and Applications
Table 22. Global Key Players of AI for Clinical and Molecular Diagnostics, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global AI for Clinical and Molecular Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 25. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Type (2021–2026)
Table 26. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Type (2027–2032)
Table 28. Global AI for Clinical and Molecular Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 29. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Application (2021–2026)
Table 30. Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Application (2027–2032)
Table 32. North America AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 34. North America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 35. Europe AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 37. Europe AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche AI for Clinical and Molecular Diagnostics Product
Table 50. Roche Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 51. Roche Recent Development
Table 52. Fujifilm Company Details
Table 53. Fujifilm Business Overview
Table 54. Fujifilm AI for Clinical and Molecular Diagnostics Product
Table 55. Fujifilm Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 56. Fujifilm Recent Development
Table 57. Illumina Company Details
Table 58. Illumina Business Overview
Table 59. Illumina AI for Clinical and Molecular Diagnostics Product
Table 60. Illumina Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 61. Illumina Recent Development
Table 62. GE HealthCare Company Details
Table 63. GE HealthCare Business Overview
Table 64. GE HealthCare AI for Clinical and Molecular Diagnostics Product
Table 65. GE HealthCare Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 66. GE HealthCare Recent Development
Table 67. Philips Company Details
Table 68. Philips Business Overview
Table 69. Philips AI for Clinical and Molecular Diagnostics Product
Table 70. Philips Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 71. Philips Recent Development
Table 72. Medtronic Company Details
Table 73. Medtronic Business Overview
Table 74. Medtronic AI for Clinical and Molecular Diagnostics Product
Table 75. Medtronic Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 76. Medtronic Recent Development
Table 77. Microsoft Company Details
Table 78. Microsoft Business Overview
Table 79. Microsoft AI for Clinical and Molecular Diagnostics Product
Table 80. Microsoft Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 81. Microsoft Recent Development
Table 82. Siemens Healthineers Company Details
Table 83. Siemens Healthineers Business Overview
Table 84. Siemens Healthineers AI for Clinical and Molecular Diagnostics Product
Table 85. Siemens Healthineers Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 86. Siemens Healthineers Recent Development
Table 87. Intel Company Details
Table 88. Intel Business Overview
Table 89. Intel AI for Clinical and Molecular Diagnostics Product
Table 90. Intel Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 91. Intel Recent Development
Table 92. Enlitic Company Details
Table 93. Enlitic Business Overview
Table 94. Enlitic AI for Clinical and Molecular Diagnostics Product
Table 95. Enlitic Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 96. Enlitic Recent Development
Table 97. NVIDIA Company Details
Table 98. NVIDIA Business Overview
Table 99. NVIDIA AI for Clinical and Molecular Diagnostics Product
Table 100. NVIDIA Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 101. NVIDIA Recent Development
Table 102. Qure AI Company Details
Table 103. Qure AI Business Overview
Table 104. Qure AI AI for Clinical and Molecular Diagnostics Product
Table 105. Qure AI Revenue in AI for Clinical and Molecular Diagnostics Business (US$ Million), 2021–2026
Table 106. Qure AI Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. AI for Clinical and Molecular Diagnostics Picture
Figure 2. Global AI for Clinical and Molecular Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AI for Clinical and Molecular Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Software Features
Figure 5. Services Features
Figure 6. Hardware Features
Figure 7. Global AI for Clinical and Molecular Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 8. Global AI for Clinical and Molecular Diagnostics Market Share by Application: 2025 vs 2032
Figure 9. Clinical Diagnostics Case Studies
Figure 10. Molecular Diagnostics Case Studies
Figure 11. AI for Clinical and Molecular Diagnostics Report Years Considered
Figure 12. Global AI for Clinical and Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global AI for Clinical and Molecular Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global AI for Clinical and Molecular Diagnostics Market Share by Region: 2025 vs 2032
Figure 15. Global AI for Clinical and Molecular Diagnostics Market Share by Players in 2025
Figure 16. Global AI for Clinical and Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by AI for Clinical and Molecular Diagnostics Revenue in 2025
Figure 18. North America AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 20. United States AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 24. Germany AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific AI for Clinical and Molecular Diagnostics Market Share by Region (2021–2032)
Figure 32. China AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 40. Mexico AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa AI for Clinical and Molecular Diagnostics Market Share by Country (2021–2032)
Figure 44. Israel AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE AI for Clinical and Molecular Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Roche Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 48. Fujifilm Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 49. Illumina Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 50. GE HealthCare Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 51. Philips Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 52. Medtronic Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 53. Microsoft Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 54. Siemens Healthineers Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 55. Intel Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 56. Enlitic Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 57. NVIDIA Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 58. Qure AI Revenue Growth Rate in AI for Clinical and Molecular Diagnostics Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
